Healthcare Innovation Fund IV, LLC — Form D/A
Healthcare Innovation Fund IV, LLC of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2022-11-03. $64.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-11-03
- Form: D/A
- Accession: 0001012975-22-000477
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $64.0M
- Minimum investment: $250K
- Investors: 122
- Date of first sale: 2022-07-27
- Security types: fund interests
- SEC file number: 021-455168
Issuer
- Name: Healthcare Innovation Fund IV, LLC
- CIK: 0001936693
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: J.P. MORGAN PRIVATE INVESTMENTS INC., NEW YORK, NY, 10179
- Phone: 212-270-8867
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| N/A J.P. Morgan Private Investments Inc. | Executive Officer | New York, NY |
| N/A J.P. Morgan Private Investments Inc. | Promoter | New York, NY |
| Darren Gorman | Director | Luxembourg, N4 |
| Martin Vogel | Director | Luxembourg, N4 |
| Catherine Crowley | Director | New York, NY |
| Caoimhghin O'Donnell | Director | Luxembourg, N4 |
Other filings by this issuer (3)
More